<DOC>
	<DOC>NCT01790789</DOC>
	<brief_summary>The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.</brief_summary>
	<brief_title>Stress Reduction in Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Subjects must have an initial diagnosis of ovarian, fallopian tube or primary peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of neoadjuvant chemotherapy with interval cytoreductive surgery (ICS). Final pathology diagnosis of stage IIV ovarian, fallopian tube or primary peritoneal cancer with plan to receive primary adjuvant chemotherapy or completion of chemotherapy after ICS. Receive chemotherapy at the University of WisconsinMadison. Subjects must be at least 18 years of age. Englishspeaking Subjects must be able to use audio media, and read and understand the study manual. ECOG performance status 02. Subjects must have a phone. Subjects participating in a meditation practice more than 1 hour per week prior to surgery and/or chemotherapy administration. Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer. Subjects with diagnosis of Chronic Fatigue Syndrome (CFS). Subjects unable to use audio media due to auditory dysfunction. Subjects unable to read written English. Subjects who are prisoners or incarcerated.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>